A detailed history of Clearbridge Investments, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Clearbridge Investments, LLC holds 245,394 shares of BMRN stock, worth $16.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
245,394
Previous 259,573 5.46%
Holding current value
$16.4 Million
Previous $21.4 Million 19.29%
% of portfolio
0.01%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$69.02 - $93.84 $978,634 - $1.33 Million
-14,179 Reduced 5.46%
245,394 $17.2 Million
Q2 2024

Aug 14, 2024

SELL
$74.43 - $92.22 $113,803 - $141,004
-1,529 Reduced 0.59%
259,573 $21.4 Million
Q1 2024

May 13, 2024

SELL
$83.81 - $99.0 $816,393 - $964,359
-9,741 Reduced 3.6%
261,102 $22.8 Million
Q4 2023

Feb 09, 2024

SELL
$76.22 - $98.51 $12.2 Million - $15.8 Million
-160,576 Reduced 37.22%
270,843 $26.1 Million
Q3 2023

Nov 13, 2023

SELL
$85.07 - $94.48 $149,553 - $166,095
-1,758 Reduced 0.41%
431,419 $38.2 Million
Q2 2023

Aug 11, 2023

SELL
$86.68 - $100.3 $3.29 Million - $3.8 Million
-37,906 Reduced 8.05%
433,177 $37.5 Million
Q1 2023

May 12, 2023

SELL
$87.74 - $117.27 $55.4 Million - $74 Million
-631,206 Reduced 57.26%
471,083 $45.8 Million
Q4 2022

Feb 10, 2023

SELL
$80.93 - $108.63 $5.78 Million - $7.76 Million
-71,414 Reduced 6.08%
1,102,289 $114 Million
Q3 2022

Nov 14, 2022

BUY
$82.16 - $96.94 $3.99 Million - $4.71 Million
48,615 Added 4.32%
1,173,703 $99.5 Million
Q2 2022

Aug 11, 2022

SELL
$71.48 - $86.85 $70.4 Million - $85.5 Million
-984,288 Reduced 46.66%
1,125,088 $93.2 Million
Q1 2022

May 13, 2022

SELL
$74.28 - $92.69 $234 Million - $292 Million
-3,154,216 Reduced 59.93%
2,109,376 $163 Million
Q4 2021

Feb 11, 2022

BUY
$71.72 - $91.47 $5.32 Million - $6.79 Million
74,239 Added 1.43%
5,263,592 $465 Million
Q3 2021

Nov 12, 2021

BUY
$74.77 - $85.47 $8.83 Million - $10.1 Million
118,050 Added 2.33%
5,189,353 $401 Million
Q2 2021

Aug 13, 2021

BUY
$75.51 - $84.79 $5.08 Million - $5.71 Million
67,333 Added 1.35%
5,071,303 $423 Million
Q1 2021

May 13, 2021

SELL
$74.73 - $90.69 $76.1 Million - $92.4 Million
-1,018,442 Reduced 16.91%
5,003,970 $378 Million
Q4 2020

Feb 10, 2021

SELL
$72.61 - $90.2 $10.9 Million - $13.5 Million
-149,916 Reduced 2.43%
6,022,412 $528 Million
Q3 2020

Nov 12, 2020

BUY
$71.87 - $131.03 $18.9 Million - $34.4 Million
262,570 Added 4.44%
6,172,328 $470 Million
Q2 2020

Aug 14, 2020

SELL
$79.55 - $124.22 $32.1 Million - $50.2 Million
-403,944 Reduced 6.4%
5,909,758 $729 Million
Q1 2020

May 15, 2020

BUY
$71.37 - $96.85 $8.22 Million - $11.2 Million
115,236 Added 1.86%
6,313,702 $534 Million
Q4 2019

Feb 14, 2020

BUY
$64.27 - $86.37 $10 Million - $13.5 Million
155,752 Added 2.58%
6,198,466 $521 Million
Q3 2019

Nov 14, 2019

BUY
$67.4 - $85.11 $4.61 Million - $5.82 Million
68,440 Added 1.15%
6,042,714 $407 Million
Q2 2019

Aug 14, 2019

BUY
$80.35 - $93.9 $77.9 Million - $91 Million
968,956 Added 19.36%
5,974,274 $0
Q1 2019

May 15, 2019

BUY
$84.2 - $98.62 $42.1 Million - $49.3 Million
499,656 Added 11.09%
5,005,318 $445 Million
Q4 2018

Feb 14, 2019

BUY
$80.14 - $106.07 $36.5 Million - $48.3 Million
455,271 Added 11.24%
4,505,662 $384 Million
Q3 2018

Nov 14, 2018

BUY
$93.92 - $105.72 $35.6 Million - $40.1 Million
378,902 Added 10.32%
4,050,391 $393 Million
Q2 2018

Aug 14, 2018

BUY
$76.01 - $99.03 $171 Million - $223 Million
2,253,624 Added 158.94%
3,671,489 $346 Million
Q1 2018

May 15, 2018

BUY
$77.67 - $92.63 $5.49 Million - $6.55 Million
70,699 Added 5.25%
1,417,865 $115 Million
Q4 2017

Feb 14, 2018

SELL
$80.76 - $95.13 $3.53 Million - $4.16 Million
-43,724 Reduced 3.14%
1,347,166 $120 Million
Q3 2017

Nov 14, 2017

BUY
$80.6 - $94.95 $2.83 Million - $3.33 Million
35,068 Added 2.59%
1,390,890 $129 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,355,822
1,355,822 $123 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Clearbridge Investments, LLC Portfolio

Follow Clearbridge Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.